Performance of the 2016 ACR-EULAR myositis response criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles.

Didem Saygin,Hanna Kim,Christian Douglas,Brian Erman,Jesse Wilkerson,John A McGrath,Chester V Oddis,Ingrid E Lundberg,Anthony A Amato,Ignacio García-De La Torre,Hector Chinoy,David Fiorentino,Lorinda Chung,Yeong-Wook Song,Frederick W Miller,Nicolino Ruperto,Jiri Vencovsky,Rohit Aggarwal,Lisa G Rider

ARTHRITIS & RHEUMATOLOGY（2023）

引用 1|浏览6

暂无评分

摘要

The ACR-EULAR MRC performs consistently across multiple studies, further supporting its use as an efficacy end point in future myositis therapeutic trials.

查看译文

关键词

Dermatomyositis,clinical trial,myositis,outcome assessment,outcome measure,polymyositis,response criteria

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要